Relmada Therapeutics Stock Forecast

RLMD's stock price has decreased by -92.08% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Relmada Therapeutics stock have an average target of 4.25, with a low estimate of 1.00 and a high estimate of 13. The average target predicts an increase of 1,215.79% from the current stock price of 0.32.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$4.25	$2.00	$13
Change	+209.60%	+1215.8%	+519.20%	+3924.8%

* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

The average analyst rating for Relmada Therapeutics stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	2	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Uy Ear Mizuho	Mizuho	Buy → Hold Downgrades $23 → $1	Buy → Hold	Downgrades	$23 → $1	+209.60%	Dec 5, 2024
Marc Goodman Leerink Partners	Leerink Partners	Buy → Hold Downgrades $10 → $1	Buy → Hold	Downgrades	$10 → $1	+209.60%	Dec 4, 2024
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $3.5 → $13	Hold → Strong Buy	Upgrades	$3.5 → $13	+3,924.77%	Sep 17, 2024
Andrea Tan Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $3 → $2	Hold → Strong Sell	Downgrades	$3 → $2	+519.20%	Jun 5, 2024
Vamil Divan Mizuho	Mizuho	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+7,949.54%	Jun 15, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.17

from -2.65

EPS Next Year

-1.65

from -1.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	10.20M	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-3.81	-7.16	-5.30	-3.28	-2.65	-1.17	-1.65	-0.84
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	31.5M	n/a
Avg	n/a	10.2M	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.16	-0.05	-0.86
Avg	-1.17	-1.65	-0.84
Low	-2.14	-3.04	-0.80

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.